Glaucoma and Cataract Surgery Market Size, Share, By Product Type (Glaucoma Surgical Device and Cataract Surgical Device), Surgery Type [Glaucoma Surgery and Cataract Surgery), End-User (Hospital, Ophthalmology Clinic, Outpatient Surgery Center, and Others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the glaucoma and cataract surgery market size is expected to reach USD 8.3 Billion.
• In 2024, the market was valued at a valuation of USD 4.0 Billion.
• It is expected that the market will grow at a CAGR of 7.8%.

Glaucoma and cataract surgery refers to a surgical procedure where an ophthalmologist concurrently treats both glaucoma, which is a condition where eye pressure damages the optical nerve, and cataracts, that is, the clouding of the eye lens, during a single operation, basically removing the cataract while also taking way to lower the eye pressure and manage the glaucoma.

There are certain benefits of glaucoma and cataract surgery. This includes improved vision, reduced eye pressure, reduced need for medication, fewer risks, better quality of life due to restoration of independence and improving night vision, and also long-lasting results. These factors contribute in fueling the glaucoma and cataract surgery market growth. Moreover, technological advancements, increase in the aging population, increased awareness, and the demand for minimally invasive procedures contribute in further market diversification.

AI Impact on the Market:

Artificial intelligence (AI) is significantly impacting both glaucoma and cataract surgery by perfecting diagnostic accuracy, optimizing treatment planning, aiding during surgery with real- time feedback, and potentially prognosticating disease progression, allowing for earlier intervention and better case issues in both conditions; particularly in areas such as intraocular lens power computation for cataract surgery and relating subtle signs of glaucoma through advanced image analysis.

Key Drivers of Target Market:

Potential of Glaucoma and Cataract Surgery to Improve Vision is Contributing to Market Growth

Glaucoma and cataract surgery leads to significant improvement in vision, as the procedure removes the cloudy lens causing blurry vision due to cataract while it also helps in managing the eye pressure associated to glaucoma. Additionally, it removes the need for additional glaucoma medications as cataract surgery can sometimes lower the intraocular pressure slightly in several cases.

• For Instance, in August 2020, Johnson & Johnson Vision launched TECNIS Synergy and TECNIS Eyhance Intraocular Lenses (IOLs) for the treatment of cataracts in Canada. The TECNIS Synergy, was a breakthrough solution that delivered continuous high-contrast vision from far through near, allowing patients to see at its ideal distances, and provide superior low-light contrast benefits from day to night.

Restraints:

Bleeding During Glaucoma and Cataract Surgery Can Hinder the Market Growth

Bleeding during or after glaucoma and cataract surgery can be a very serious challenge, and it can range from mild to severe. Bleeding can occur when blood vessels in the retina leak. It can also lead to procedural failure or irreversible optic nerve damage. Patients taking antiplatelet (AP) and anticoagulant (AC) agents may be at higher risk of bleeding. Bleeding is more certain to occur if the surgeon tears the scleral flap during surgery. This factor acts as a hindrance to the glaucoma and cataract surgery market expansion.

• Counterbalance Statements: Intracameral injection of phenylephrine, direct pressure, irrigation, and drainage via AC Paracentesis, are the possible solutions to control and stop the bleeding during the surgery.

Opportunities:

Unification of Advanced Technologies with the Glaucoma and Cataract Surgery can Unlock Growth Potential in Upcoming Years

Advanced technologies of glaucoma and cataract surgery can help in faster recovery, reduced risk of complications, and improved long-term vision. Some of the advanced technologies for glaucoma surgery include, iStent, Canaloplaasty, GATT (Gonioscopy-Assisted Transluminal Trabeculotomy), iDose TR Implant, and other technologies. Some advanced technologies of cataract surgery include, femtosecond laser-assisted cataract surgery (FLACS), small incision cataract surgery, laser cataract surgery, and other technologies. These advanced technologies, unlock the growth potential of this market.

• For instance, in June 2022, HelpMeSee, announced the release of an eBook on manual small incision cataract surgery (MSICS) that provided an immense learning experience through rich multimedia, live surgical demonstrations and a step-by-step guide to the surgical procedure. Its main focus was to help ophthalmologists refine skills for successful cataract surgery.

The market is categorized into product type, surgery type, end-user, and region.

Product Type

On the basis of product type, the market is catalogued into glaucoma surgical devices and cataract surgery device. The cataract surgical devices segment holds the largest glaucoma and cataract surgery market share due to the increasing demand of cataract surgery. Cataract is generally caused due age factors as there is a rise in elderly population, it also rises the demand for and cataract surgical devices.

• For instance, in September 2024, Alcon, the global leader in eye care, announced new innovations during the European Society of Cataract and Refractive Surgeons (ESCRS) Annual Meeting. This included SMARTCataract DX digital planning solution which was designed to power workflow efficiencies for practices, and it was driven by ARGOS Biometer and future Alcon diagnostic technologies.

Surgery Type

The market is bifurcated into glaucoma surgery and cataract surgery, hinging on the surgery type. The glaucoma surgery segment dominated the market due to the increasing demand of minimally invasive glaucoma surgery (MIGS). MIGS is a minimally invasive procedure that uses micro-incisions to reduce trauma to the target tissue.

• For instance, in December 2024, Bausch + Lomb Corporation, a leading global eye health company, announced that an affiliate acquired Elios Vision, Inc., developer of the ELIOS procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. The acquisition unlocked new opportunities to treat glaucoma effectively in conjunction with cataract surgery without implants and bolstered Bausch + Lomb’s glaucoma portfolio, which featured pharmaceutical and surgical approaches.

End-User

On the premise of end user, the market is pigeonholed into hospital, ophthalmology clinic, outpatient surgery centre, and others. The hospitals are the end users governing the market, due to its access to advanced surgical equipment, a large patient base, and the availability of highly skilled ophthalmologists for performing the surgery in a hassle-free manner.

• For instance, in May 2022, ASG Eye Hospitals inaugurated a facility in Maharashtra, India, giving patients easy access to world-class holistic eye care. The group planned on strengthening its presence by opening 10 more hospitals in the region. The super-specialty eye care hospital was equipped with the latest in ophthalmology technology for cutting-edge diagnosis and treatment of complex eye conditions such as glaucoma, cataract, and other eye conditions.

Region

Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region has the largest glaucoma and cataract surgery market share for the glaucoma and cataract surgery market. This is due to the region’s high prevalence of eye diseases, well-established healthcare infrastructure, strong research and development activities, and the initiatives of the government to raise awareness about eye.

• For instance, in November 2024, Eye Health America (EHA), a leading integrated eyecare platform, announced its strategic partnership with Bowden Eye & Associates, a renowned ophthalmology practice in Florida. This partnership enabled the continuity of cutting-edge specialty eye care services such as glaucoma and cataract surgery, and other services to the community of Northeast Florida.

Europe: This region is attributed to have the fastest growing market during the forecast period due to the region’s large aging population, reimbursement policies for glaucoma and cataract surgery, well-developed healthcare infrastructure, and increasing adoption of advanced surgical technologies.

• For instance, in February 2024, Sight Sciences, Inc. announced the launch of the Ergo-Series of the OMNI Surgical System in Europe. This series was launched to enhance ophthalmic surgeons’ ability to perform minimally invasive, implant-free glaucoma procedures. The technology boasted enhanced ergonomics, including a cannula tip optimized for precision and comfortable use.

Glaucoma and Cataract Surgery Market Report Scope:

Segmentation:

By Product Type:

• Glaucoma Surgical Device
  • Implant and Stent
  • Glaucoma Drainage
  • Glaucoma Laser Device
  • Others
• Cataract Surgical Device
  • Intraocular Lens
  • Ophthalmic Viscoelastic Device
  • Phacoemulsification System
  • Others

By Surgery Type:

• Glaucoma Surgery
  • Conventional Glaucoma Surgery
  • Minimally Invasive Glaucoma Surgery
• Cataract Surgery
  • Phacoemulsification
  • Extracapsular Cataract Extraction (ECCE) surgery
  • Femtosecond Laser Surgery
  • Others

By End User:

• Hospital
• Ophthalmology Clinic
• Outpatient Surgery Center
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the market are adopting strategies, such as launching minimally invasive devices, technological advancements in implants and surgical techniques, strategic partnerships, and acquisitions. Some of the companies operating in this sector are Alcon Inc., NIDEK CO., LTD., Essilor Solutions, Glaukos Corporation, Johnson & Johnson Services, Inc., and others.

View a additional list of companies in the Glaucoma and Cataract Surgery Market:

• Alcon Inc.
• NIDEK CO., LTD.
• Essilor Solutions
• Glaukos Corporation
• Johnson & Johnson Services, Inc.
• AbbVie Inc.
• Santen Pharmaceutical Co., Ltd.
• ASG Hospital Pvt. Ltd.
• Abbott
• Bausch + Lomb
• Lumenis Be Ltd.
• Carl Zeiss Meditec AG
• New World Medical, Inc.
• TOPCON CORPORATION

• In November 2024, a new learning lab at Carle Illinois College of Medicine provided medical students with training in cutting-edge surgical treatment for glaucoma, the world’s second leading cause of blindness. The new microinvasive glaucoma surgery (MiGS) lab was a first-of-its-kind wet lab learning opportunity for CI MED students, with hands-on training in less-invasive surgical options for preserving glaucoma patients’ sight.
• In September 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, were to present compelling scientific data at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Barcelona, Spain. Numerous abstracts would highlight Alcon’s leading surgical ophthalmic products and equipment, designed for optimized patient outcomes and operational efficiencies.

Analyst View:

Surgery for cataracts and glaucoma has certain advantages. Long-lasting benefits include greater vision, lower eye pressure, less medicine, fewer dangers, and a higher quality of life as a result of regaining independence and seeing better at night. These elements fuels the glaucoma and cataract surgery market expansion.

More Related Reports

Glaucoma Therapeutics Market
Neurosurgery Market
BioSurgery Market
Spinal Surgery Devices Market
Cardiac Surgery Equipment Market